Population pharmacokinetics and cerebrospinal fluid penetration of fluconazole in adults with cryptococcal meningitis
Robust population pharmacokinetic (PK) data for fluconazole are scarce. The variability of fluconazole penetration into the CNS is not known. A fluconazole PK study was conducted in 43 patients receiving oral fluconazole (usually 800 mg q24h) in combination with amphotericin B deoxycholate (1 mg/kg...
Main Authors: | Stott, K, Beardsley, J, Kolamunnage-Dona, R, Santoyo Castelazo, A, Kibengo, F, Mai, N, Day, J, Hope, W |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society for Microbiology
2018
|
Similar Items
-
Population pharmacokinetic model and meta-analysis of outcomes of amphotericin B deoxycholate use in adults with cryptococcal meningitis
by: Stott, K, et al.
Published: (2018) -
A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis
by: Ngan, N, et al.
Published: (2019) -
An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis
by: Ngan, NTT, et al.
Published: (2021) -
Cerebrospinal fluid HIV-1 viral load during treatment of cryptococcal Meningitis.
by: Brouwer, A, et al.
Published: (2010) -
The authors reply: Dexamethasone in Cryptococcal Meningitis
by: Beardsley, J, et al.
Published: (2016)